Genmab — Februar 2019
-
God morgen. :-). DB skifter focus fra amerikanske aktier til EU aktier. Bla. sundhed. https://danskebank.dk/privat/news/investeringsnyt/forside---investeringsnyt/nu-slaar-vi-til-paa-europaeisk-aktietilbud?sc_cid=em|apsis|pb-art-invest-na-62019|1
-
https://www.linkedin.com/feed/update/urn:li:activity:6499650791236784128 Tisotumab med kommentarer mv
-
Tak Solsens...David giver den fuld skrue.
-
Solsens..Jeg har lagt dit link i debatten: http://www.proinvestor.com/index.php?p=debat_1&postid=76680
-
Ja, der bliver ikke sparet på superlativerne. Det kunne være spændende om han kunne uddybe, hvordan han kom til 2 bn. Hvis det er et tal taget ud af det blå, burde det også fremgå. Jeg mener han også er aktiv her i debatten, så måske han kunne sætte lidt flere ord på.
-
@ Bibob: Tak for dit link ovre i aktiesnakken om Novos orale leveringsform. Her er en anden artikel, som gør det Genmab-relevant. Et lille citat herfra: Future programmes using the Soma device might look at antibodies for rheumatoid arthritis or even nucleic acid therapeutics, says MIT. Man ser det for sig: Dara i tabletform. http://www.evaluate.com/vantage/articles/interviews/novo-nordisk-sticks-its-neck-out-tech-promises-oral-insulin
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind